For laboratory & research use only. Not for human consumption.
Cognitive & Nootropic

Semax Mechanism of Action

How a stabilized fragment of ACTH lost its parent hormone's cortisol-stimulating activity but kept -- and extended -- its neurotrophic effects.

A Fragment That Lost ACTH's Hormonal Activity

Semax is built around ACTH(4-7), a four-amino-acid fragment of adrenocorticotropic hormone (ACTH). Critically, this fragment lacks the receptor-binding region responsible for ACTH's classic hormonal role of stimulating cortisol production — research had already established that ACTH(4-7) carried nootropic, neurotrophic effects entirely independent of that hormonal activity before Semax was created.

Stabilization Extends a Fragment That Degraded Too Quickly

ACTH(4-7) on its own degraded far too quickly in the body to be practically useful for research. Semax's developers fused the same stabilizing tripeptide (proline-glycine-proline) later used for Selank onto the ACTH(4-7) fragment, extending its functional half-life. The Pro-Gly-Pro addition is reported to also contribute independent anti-inflammatory activity of its own, on top of stabilizing the base fragment.

Elevating BDNF and Modulating Monoamine Systems

Semax research models report increased brain-derived neurotrophic factor (BDNF) expression, particularly in the hippocampus, along with modulation of dopamine and serotonin systems. Separately, Semax has shown neuroprotective effects in ischemia (restricted blood flow) research models, proposed to work through anti-inflammatory and antioxidant pathways rather than any receptor activity related to ACTH's original hormonal function.

How This Differs From Selank

Selank reaches similar BDNF-elevating neurotrophic territory from a completely different starting point — a stabilized fragment of the immune peptide tuftsin, rather than a stabilized fragment of ACTH. See our full Semax vs Selank comparison for more detail on how the two compare.

  • BDNF expression and hippocampal neurotrophic research
  • Dopamine and serotonin system modulation studies
  • Neuroprotective research in ischemia models
  • Comparative mechanism research vs Selank

Back to the full Semax research overview →

Research Use Only Notice This page provides general research and educational context about Semax's mechanism of action only, and does not constitute medical, dosing, or human-use advice. It is not a claim about current regulatory approval, safety, or legal status in any market. Any Semax sourced through KYIN Peptides is sold strictly for laboratory research use by qualified professionals — not for human or animal use, and not intended for diagnostic, therapeutic, or consumption purposes.
FAQ

Semax mechanism questions

Does Semax act like ACTH and stimulate cortisol?

No. Semax is built around the ACTH(4-7) fragment, which lacks the receptor-binding region responsible for ACTH's hormonal cortisol-stimulating activity. Its research effects work through separate BDNF and monoamine-related pathways.

How does Semax's mechanism compare to Selank's?

Both elevate BDNF and use the same Pro-Gly-Pro stabilization technique, but they start from different parent molecules: Semax from a fragment of ACTH, and Selank from the immune peptide tuftsin.

Interested in Semax?

See pricing and order on the product page, or browse our other cognitive and nootropic peptides.